287 results on '"Höglinger, G"'
Search Results
2. Correction to: Role of dopamine agonists in Parkinson's disease therapy
3. Recurrent infarcts from thyroid cartilage compression of an aberrant vertebral artery: rare, easily overlooked, but treatable
4. Role of dopamine agonists in Parkinson's disease therapy
5. Disease modification in Parkinsonism: obstacles and ways forward
6. Allogene virusspezifische T‑Zellen als innovative Therapieoption: Behandlung der progressiven multifokalen Leukenzephalopathie mit allogenen virusspezifischen T‑Zellen
7. Massivste epigastrische Schmerzen bei einem 59-jährigen Patienten
8. Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
9. 56/m mit therapierefraktärem akinetisch-rigidem Syndrom: Vorbereitung auf die Facharztprüfung: Fall 19
10. Correction to: Role of dopamine agonists in Parkinson's disease therapy
11. Erratum zu: Massivste epigastrische Schmerzen bei einem 59-jährigen Patienten
12. Tauopathien: Vom Molekül zur Therapie
13. Pharmakotherapie des Morbus Parkinson: Aspekte der Arzneimitteltherapiesicherheit
14. Subcortical tau-accumulation predicts neuronal dysfunction in the cortex based on functional connectivity in 4R-tauopathies
15. Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy
16. Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.
17. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
18. Allogene virusspezifische T‑Zellen als innovative Therapieoption
19. Long-term treatment with l-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinsonʼs disease
20. Feasibility of short imaging protocols for [18F]PI-2620 tau‐PET in progressive supranuclear palsy
21. Magnetic resonance imaging in progressive supranuclear palsy
22. Clinical predictors of survival in patients with progressive supranuclear palsy: 324
23. Co-pathology and clinical correlation in progressive supranuclear palsy: 302
24. MRI plani- and volumetry in the diagnosis of progressive supranuclear palsy: 220
25. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice: 100
26. Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and non-motor behavior in a mouse model of Parkinsonʼs disease: 79
27. Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment
28. LRP1: A Novel Mediator of Tau Uptake
29. Aetiopathology: FW 11-3
30. Kaurenoic Acid from Pulp of Annona cherimolia in regard to Annonaceae-induced Parkinsonism
31. Stem cell research: from application in human disease to basic mechanisms: Theme I. 6
32. Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
33. Massivste epigastrische Schmerzen bei einem 59-jährigen Patienten
34. Characterization of diagnostic certainty levels and clinical syndromes in patients with progressive supranuclear palsy in two German prospective cohorts
35. Development and validation of a PSP questionnaire as screening tool for early diagnosis of progressive supranuclear palsy (PSP)
36. miRNA sequencing from routine colonic biopsies reveals an enrichment of mucosal hsa-miRNA-486-5p in Parkinson's disease
37. Binding characteristics of 18 F-PI-2620 differentiate the clinically predicted tau isoform in suspected 3/4-repeat and 4-repeat tauopathies
38. Preclinical head-to-head comparison of SV2A-PET with FDG-PET and structural MRI in a tau mouse model
39. 18 F-PI2620 Tau-PET in Progressive Supranuclear Palsy – A Multi-Center Evaluation
40. Dual-phase β-Amyloid PET for Assessment of Neuronal Injury and Amyloidosis in Corticobasal Syndrome
41. Perfusion-Phase 18 F-PI-2620 Tau-PET Imaging as a Surrogate Marker of Neuronal Injury
42. 18 F-PI2620 Tau-PET for Assessment of Heterogeneous Neuropathology in Corticobasal Syndrome
43. Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson’s Disease Patients
44. Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?
45. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options
46. Options for Disease Modifying Interventions in Progressive Supranuclear Palsy
47. Animal models of Parkinson’s disease in rodents induced by toxins: an update
48. Frühdiagnose des Morbus Parkinson
49. Quantitative [123I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinsonʼs disease
50. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.